Even H. Rustad

885 total citations
13 papers, 306 citations indexed

About

Even H. Rustad is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, Even H. Rustad has authored 13 papers receiving a total of 306 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Hematology, 10 papers in Molecular Biology and 3 papers in Oncology. Recurrent topics in Even H. Rustad's work include Multiple Myeloma Research and Treatments (11 papers), Protein Degradation and Inhibitors (6 papers) and Cancer Genomics and Diagnostics (3 papers). Even H. Rustad is often cited by papers focused on Multiple Myeloma Research and Treatments (11 papers), Protein Degradation and Inhibitors (6 papers) and Cancer Genomics and Diagnostics (3 papers). Even H. Rustad collaborates with scholars based in United States, Norway and Italy. Even H. Rustad's co-authors include Anders Sundan, Anders Waage, Therese Standal, Anne‐Marit Sponaas, Emadoldin Feyzi, Eileen M. Boyle, Elli Papaemmanuil, Malin Hultcrantz, Ola Landgren and Hong Dai and has published in prestigious journals such as PLoS ONE, Clinical Cancer Research and Oncotarget.

In The Last Decade

Even H. Rustad

13 papers receiving 303 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Even H. Rustad United States	9	214	159	147	67	52	13	306
Johannes M. Waldschmidt Germany	9	207 1.0×	149 0.9×	158 1.1×	45 0.7×	40 0.8×	53	310
Sofia von Palffy Sweden	7	271 1.3×	137 0.9×	94 0.6×	100 1.5×	55 1.1×	11	440
Taku Tsukamoto Japan	10	99 0.5×	162 1.0×	116 0.8×	44 0.7×	32 0.6×	50	304
Sylvain Garciaz France	11	133 0.6×	113 0.7×	117 0.8×	64 1.0×	16 0.3×	46	324
Ellen Ingalla United States	5	127 0.6×	241 1.5×	126 0.9×	32 0.5×	29 0.6×	12	339
Kenneth Anderson United States	9	131 0.6×	119 0.7×	74 0.5×	45 0.7×	25 0.5×	13	273
Patricia Kropf United States	9	138 0.6×	193 1.2×	59 0.4×	49 0.7×	32 0.6×	26	341
Jennifer D. Morrissette United States	7	161 0.8×	156 1.0×	88 0.6×	41 0.6×	57 1.1×	11	311
Neil Palmisiano United States	13	162 0.8×	156 1.0×	228 1.6×	120 1.8×	36 0.7×	64	491
Jing Christine Ye United States	7	82 0.4×	89 0.6×	139 0.9×	61 0.9×	30 0.6×	20	262

Countries citing papers authored by Even H. Rustad

Since Specialization

Citations

This map shows the geographic impact of Even H. Rustad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Even H. Rustad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Even H. Rustad more than expected).

Fields of papers citing papers by Even H. Rustad

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Even H. Rustad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Even H. Rustad. The network helps show where Even H. Rustad may publish in the future.

Co-authorship network of co-authors of Even H. Rustad

This figure shows the co-authorship network connecting the top 25 collaborators of Even H. Rustad. A scholar is included among the top collaborators of Even H. Rustad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Even H. Rustad. Even H. Rustad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

1.

Chojnacka, Monika, Benjamin Diamond, Bachisio Ziccheddu, et al.. (2023). Impact of Rare Structural Variant Events in Newly Diagnosed Multiple Myeloma. Clinical Cancer Research. 30(3). 575–585. 1 indexed citations

2.

Hultcrantz, Malin, Even H. Rustad, Venkata Yellapantula, et al.. (2022). Capture Rate of V(D)J Sequencing for Minimal Residual Disease Detection in Multiple Myeloma. Clinical Cancer Research. 28(10). 2160–2166. 1 indexed citations

3.

D’Agostino, Mattia, Gian Maria Zaccaria, Bachisio Ziccheddu, et al.. (2020). Early Relapse Risk in Patients with Newly Diagnosed Multiple Myeloma Characterized by Next-generation Sequencing. Clinical Cancer Research. 26(18). 4832–4841. 38 indexed citations

4.

Yellapantula, Venkata D., Malin Hultcrantz, Even H. Rustad, et al.. (2020). Correction: Comprehensive detection of recurring genomic abnormalities: a targeted sequencing approach for multiple myeloma. Blood Cancer Journal. 10(1). 1 indexed citations

5.

Rustad, Even H. & Eileen M. Boyle. (2020). Monitoring minimal residual disease in the bone marrow using next generation sequencing. Best Practice & Research Clinical Haematology. 33(1). 101149–101149. 13 indexed citations

6.

Yellapantula, Venkata D., Malin Hultcrantz, Even H. Rustad, et al.. (2019). Comprehensive detection of recurring genomic abnormalities: a targeted sequencing approach for multiple myeloma. Blood Cancer Journal. 9(12). 101–101. 35 indexed citations

7.

Kazandjian, Dickran, Elizabeth Hill, Malin Hultcrantz, et al.. (2019). Molecular underpinnings of clinical disparity patterns in African American vs. Caucasian American multiple myeloma patients. Genetics Research. 4 indexed citations

8.

Kazandjian, Dickran, Elizabeth Hill, Malin Hultcrantz, et al.. (2019). Molecular underpinnings of clinical disparity patterns in African American vs. Caucasian American multiple myeloma patients. Blood Cancer Journal. 9(2). 15–15. 32 indexed citations

9.

Rustad, Even H., Malin Hultcrantz, Venkata Yellapantula, et al.. (2019). Baseline identification of clonal V(D)J sequences for DNA-based minimal residual disease detection in multiple myeloma. PLoS ONE. 14(3). e0211600–e0211600. 22 indexed citations

10.

Sponaas, Anne‐Marit, Rui Yang, Even H. Rustad, et al.. (2018). PD1 is expressed on exhausted T cells as well as virus specific memory CD8+ T cells in the bone marrow of myeloma patients. Oncotarget. 9(62). 32024–32035. 20 indexed citations

11.

Rustad, Even H., Eivind Coward, Emilie Ranheim Skytøen, et al.. (2017). Monitoring multiple myeloma by quantification of recurrent mutations in serum. Haematologica. 102(7). 1266–1272. 41 indexed citations

12.

Sponaas, Anne‐Marit, Emadoldin Feyzi, Therese Standal, et al.. (2015). PDL1 Expression on Plasma and Dendritic Cells in Myeloma Bone Marrow Suggests Benefit of Targeted anti PD1-PDL1 Therapy. PLoS ONE. 10(10). e0139867–e0139867. 66 indexed citations

13.

Rustad, Even H., Hong Dai, Vidar Beisvåg, et al.. (2015). BRAF V600E mutation in early-stage multiple myeloma: good response to broad acting drugs and no relation to prognosis. Blood Cancer Journal. 5(3). e299–e299. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact